Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
1.180
-0.020 (-1.67%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Silo Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.28 | 4.75 | 3.91 | 3.52 | 11.37 | 9.84 |
Short-Term Investments | 1.95 | 2.11 | 3.17 | 4.14 | 0 | 0.42 |
Cash & Short-Term Investments | 5.23 | 6.86 | 7.08 | 7.67 | 11.37 | 10.26 |
Cash Growth | -16.50% | -3.13% | -7.63% | -32.58% | 10.85% | 808.83% |
Accounts Receivable | - | 0 | 0 | 0 | 0 | 0 |
Receivables | - | 0 | 0 | 0 | 0.07 | 0 |
Prepaid Expenses | 0.28 | 0.19 | 0.03 | 0.01 | 0.12 | 0.06 |
Other Current Assets | 0.21 | 0.34 | 0.01 | 0.01 | 0.02 | 0.08 |
Total Current Assets | 5.71 | 7.39 | 7.11 | 7.68 | 11.57 | 10.4 |
Other Intangible Assets | 0.21 | 0.22 | 0.24 | - | - | - |
Long-Term Accounts Receivable | - | - | 0.01 | 0.01 | 0.01 | 0.01 |
Long-Term Deferred Charges | 0.03 | - | 0.05 | 0.06 | 0.06 | 0.02 |
Total Assets | 5.95 | 7.61 | 7.41 | 7.75 | 11.64 | 10.49 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.36 | 0.58 | 1.58 | 0.7 | 0.22 | 0.42 |
Accrued Expenses | - | - | - | - | 0.14 | - |
Current Unearned Revenue | - | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
Total Current Liabilities | 1.07 | 0.65 | 1.66 | 0.78 | 0.44 | 0.49 |
Long-Term Unearned Revenue | - | 0.65 | 0.72 | 0.79 | 0.87 | 0.94 |
Total Liabilities | 1.07 | 1.3 | 2.38 | 1.57 | 1.3 | 1.43 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 26.85 | 25.79 | 20.3 | 17.53 | 17.51 | 12.32 |
Retained Earnings | -21.97 | -19.49 | -15.26 | -10.87 | -7.17 | -3.26 |
Treasury Stock | - | - | - | -0.47 | - | - |
Comprehensive Income & Other | 0.01 | 0.01 | 0 | -0.01 | - | - |
Total Common Equity | 4.89 | 6.31 | 5.03 | 6.18 | 10.34 | 9.06 |
Shareholders' Equity | 4.89 | 6.31 | 5.03 | 6.18 | 10.34 | 9.06 |
Total Liabilities & Equity | 5.95 | 7.61 | 7.41 | 7.75 | 11.64 | 10.49 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 5.23 | 6.86 | 7.08 | 7.67 | 11.37 | 10.26 |
Net Cash Growth | -16.50% | -3.13% | -7.63% | -32.58% | 10.85% | 824.31% |
Net Cash Per Share | 5.92 | 12.27 | 28.86 | 37.33 | 74.66 | 80.20 |
Filing Date Shares Outstanding | 1.59 | 0.94 | 0.3 | 0.19 | 0.21 | 0.13 |
Total Common Shares Outstanding | 1.13 | 0.89 | 0.3 | 0.19 | 0.21 | 0.13 |
Working Capital | 4.65 | 6.74 | 5.46 | 6.91 | 11.14 | 9.91 |
Book Value Per Share | 4.33 | 7.10 | 16.84 | 31.88 | 49.10 | 68.91 |
Tangible Book Value | 4.67 | 6.09 | 4.79 | 6.18 | 10.34 | 9.06 |
Tangible Book Value Per Share | 4.14 | 6.86 | 16.03 | 31.88 | 49.10 | 68.91 |